Cargando…
Correction to: Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial
Autores principales: | Maes, Bastiaan, Bosteels, Cedric, De Leeuw, Elisabeth, Declercq, Jozefien, Van Damme, Karel, Delporte, Anja, Demeyere, Bénédicte, Vermeersch, Stéfanie, Vuylsteke, Marnik, Willaert, Joren, Bollé, Laura, Vanbiervliet, Yuri, Decuypere, Jana, Libeer, Frederick, Vandecasteele, Stefaan, Peene, Isabelle, Lambrecht, Bart N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306650/ https://www.ncbi.nlm.nih.gov/pubmed/32571394 http://dx.doi.org/10.1186/s13063-020-04519-4 |
Ejemplares similares
-
Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC): A structured summary of a study protocol for a randomised controlled trial
por: Bosteels, Cedric, et al.
Publicado: (2020) -
Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial
por: Maes, Bastiaan, et al.
Publicado: (2020) -
Correction to: Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC): A structured summary of a study protocol for a randomised controlled trial
por: Bosteels, Cedric, et al.
Publicado: (2020) -
Zilucoplan in patients with acute hypoxic respiratory failure due to COVID-19 (ZILU-COV): A structured summary of a study protocol for a randomised controlled trial
por: Declercq, Jozefien, et al.
Publicado: (2020) -
Case Report: Convalescent Plasma, a Targeted Therapy for Patients with CVID and Severe COVID-19
por: Van Damme, Karel F. A., et al.
Publicado: (2020)